A wave of supplements marketed as natural alternatives to GLP-1 weight-loss drugs has drawn direct regulatory scrutiny. Here’s what to know before buying one.

Stress-and-mood supplements are one of the fastest-growing wellness categories. Here’s what the term “adaptogen” is actually claiming — and its real evidence base.

Mental performance is the single biggest driver of nootropic supplement interest in 2026. Here’s how to read the claims critically.

Gut health remains one of the largest supplement categories. Here’s what NIH’s own guidance says about probiotic evidence.

Women’s health has become one of the fastest-growing supplement categories in 2026. Here’s where the research base is genuinely solid.